{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T23:33:45Z","timestamp":1793144025629,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T00:00:00Z","timestamp":1738540800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100017686","name":"Fujian Provincial Health Technology Project","doi-asserted-by":"publisher","award":["2020QNA039"],"award-info":[{"award-number":["2020QNA039"]}],"id":[{"id":"10.13039\/501100017686","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsurgicalresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Surgical Research"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.jss.2025.01.010","type":"journal-article","created":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T12:59:24Z","timestamp":1740142764000},"page":"42-52","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Expression and Subtype Discordance Between Core Needle Biopsy and Surgical Specimen in Breast Cancer"],"prefix":"10.1016","volume":"307","author":[{"given":"Min","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1702-9139","authenticated-orcid":false,"given":"Yiwei","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueqin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangmeng","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jss.2025.01.010_bib1","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.3390\/nu11071514","article-title":"Nutrition and breast cancer: a literature review on prevention, treatment and recurrence","volume":"11","author":"De Cicco","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.jss.2025.01.010_bib2","first-page":"17","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jss.2025.01.010_bib3","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1016\/S0140-6736(20)32381-3","article-title":"Breast cancer","volume":"397","author":"Loibl","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jss.2025.01.010_bib4","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jss.2025.01.010_bib5","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.ejso.2016.10.025","article-title":"Impact of molecular subtypes classification concordance between preoperative core needle biopsy and surgical specimen on early breast cancer management: single-institution experience and review of published literature","volume":"43","author":"Meattini","year":"2017","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.jss.2025.01.010_bib6","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1093\/annonc\/mdt303","article-title":"Personalizing the treatment of women with early breast cancer: highlights of the St gallen international expert Consensus on the primary therapy of early breast cancer 2013","volume":"24","author":"Goldhirsch","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jss.2025.01.010_bib7","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1038\/s41598-021-81538-4","article-title":"Clinical implications of intrinsic molecular subtypes of breast cancer for sentinel node status","volume":"11","author":"Rossing","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.jss.2025.01.010_bib8","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1111\/j.1349-7006.2010.01630.x","article-title":"Comparison of core needle biopsy (CNB) and surgical specimens for accurate preoperative evaluation of ER, PgR and HER2 status of breast cancer patients","volume":"101","author":"Tamaki","year":"2010","journal-title":"Cancer Sci"},{"key":"10.1016\/j.jss.2025.01.010_bib9","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1111\/apm.12213","article-title":"Reliability of histological malignancy grade, ER and HER2 status on core needle biopsy vs surgical specimen in breast cancer","volume":"122","author":"Munch-Petersen","year":"2014","journal-title":"APMIS"},{"key":"10.1016\/j.jss.2025.01.010_bib10","doi-asserted-by":"crossref","first-page":"4954","DOI":"10.1002\/cam4.4843","article-title":"Concordance of breast cancer biomarker testing in core needle biopsy and surgical specimens: a single institution experience","volume":"11","author":"Slostad","year":"2022","journal-title":"Cancer Med"},{"key":"10.1016\/j.jss.2025.01.010_bib11","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1007\/s10549-012-1990-z","article-title":"Accuracy of estrogen receptor, progesterone receptor, and HER2 status between core needle and open excision biopsy in breast cancer: a meta-analysis","volume":"134","author":"Chen","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.jss.2025.01.010_bib12","first-page":"422","article-title":"Discordances in ER, PR and HER2 receptors after neoadjuvant chemotherapy in breast cancer","volume":"37","author":"van de Ven","year":"2011","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.jss.2025.01.010_bib13","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.4103\/jcrt.JCRT_601_20","article-title":"A single centre experience in Turkey for comparison between core needle biopsy and surgical specimen evaluation results for HER2, SISH, estrogen receptors and progesterone receptors in breast cancer patients","volume":"18","author":"Karaman","year":"2022","journal-title":"J Cancer Res Ther"},{"key":"10.1016\/j.jss.2025.01.010_bib14","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.canlet.2004.07.041","article-title":"Biopathologic profile of breast cancer core biopsy: is it always a valid method?","volume":"218","author":"Cavaliere","year":"2005","journal-title":"Cancer Lett"},{"key":"10.1016\/j.jss.2025.01.010_bib15","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.breast.2010.12.007","article-title":"Discordance in early breast cancer for tumour grade, estrogen receptor, progesteron receptors and human epidermal receptor-2 status between core needle biopsy and surgical excisional primary tumour","volume":"20","author":"Lorgis","year":"2011","journal-title":"Breast"},{"key":"10.1016\/j.jss.2025.01.010_bib16","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.breast.2010.04.003","article-title":"Breast lesions with ultrasound imaging-histologic discordance at 16-gauge core needle biopsy: can re-biopsy with 10-gauge vacuum-assisted system get definitive diagnosis?","volume":"19","author":"Li","year":"2010","journal-title":"Breast"},{"key":"10.1016\/j.jss.2025.01.010_bib17","doi-asserted-by":"crossref","first-page":"4000","DOI":"10.3390\/cancers14164000","article-title":"How reliable are gene expression-based and immunohistochemical biomarkers assessed on a core-needle biopsy? A study of paired core-needle biopsies and surgical specimens in early breast cancer","volume":"14","author":"Saghir","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.jss.2025.01.010_bib18","doi-asserted-by":"crossref","first-page":"4475","DOI":"10.1245\/s10434-020-08608-1","article-title":"Molecular biological features of Nottingham histological Grade 3 breast cancers","volume":"27","author":"Takahashi","year":"2020","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jss.2025.01.010_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41523-021-00308-7","article-title":"Impact of estrogen receptor levels on outcome in non-metastatic triple negative breast cancer patients treated with neoadjuvant\/adjuvant chemotherapy","volume":"7","author":"Dieci","year":"2021","journal-title":"NPJ Breast Cancer"},{"key":"10.1016\/j.jss.2025.01.010_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2021.100289","article-title":"The prognostic and predictive impact of low estrogen receptor expression in early breast cancer: a systematic review and meta-analysis","volume":"6","author":"Paakkola","year":"2021","journal-title":"ESMO Open"},{"key":"10.1016\/j.jss.2025.01.010_bib21","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1200\/JCO.19.02309","article-title":"Estrogen and progesterone receptor testing in breast cancer: ASCO\/CAP guideline update","volume":"38","author":"Allison","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jss.2025.01.010_bib22","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1200\/JCO.2006.09.2775","article-title":"American Society of Clinical Oncology\/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer","volume":"25","author":"Wolff","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jss.2025.01.010_bib23","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1200\/JCO.2013.50.9984","article-title":"Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology\/College of American Pathologists clinical practice guideline update","volume":"31","author":"Wolff","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jss.2025.01.010_bib24","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1200\/JCO.2018.77.8738","article-title":"Human epidermal growth factor receptor 2 testing in breast cancer: American society of clinical oncology\/college of American Pathologists clinical practice guideline focused update","volume":"36","author":"Wolff","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jss.2025.01.010_bib25","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1159\/000328054","article-title":"St. Gallen 2011: summary of the Consensus discussion","volume":"6","author":"Gnant","year":"2011","journal-title":"Breast Care (Basel)"},{"key":"10.1016\/j.jss.2025.01.010_bib26","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s10549-019-05141-y","article-title":"Real-world data on discordance between estrogen, progesterone, and HER2 receptor expression on diagnostic tumor biopsy versus tumor resection material","volume":"175","author":"Berghuis","year":"2019","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.jss.2025.01.010_bib27","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s10549-022-06548-w","article-title":"Concordance between core needle biopsy and surgical excision for breast cancer tumor grade and biomarkers","volume":"193","author":"Shanmugalingam","year":"2022","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.jss.2025.01.010_bib28","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1093\/annonc\/mds599","article-title":"Reliability of core needle biopsy for determining ER and HER2 status in breast cancer","volume":"24","author":"Dekker","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jss.2025.01.010_bib29","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1038\/modpathol.2012.59","article-title":"The effect of cold ischemic time on the immunohistochemical evaluation of estrogen receptor, progesterone receptor, and HER2 expression in invasive breast carcinoma","volume":"25","author":"Yildiz-Aktas","year":"2012","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jss.2025.01.010_bib30","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1309\/AJCPQRAG67GJRPMT","article-title":"The effect of 96-hour formalin fixation on the immunohistochemical evaluation of estrogen receptor, progesterone receptor, and HER2 expression in invasive breast carcinoma","volume":"137","author":"Yildiz-Aktas","year":"2012","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jss.2025.01.010_bib31","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.breast.2015.10.009","article-title":"Impact of host and histopathological factors on the discrepancies in estrogen receptor, and progesterone receptor, and HER2 status between core needle biopsy and surgically excised tumors","volume":"26","author":"Nakamura","year":"2016","journal-title":"Breast"},{"key":"10.1016\/j.jss.2025.01.010_bib32","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1159\/000351193","article-title":"St. Gallen 2013: brief preliminary summary of the Consensus discussion","volume":"8","author":"Harbeck","year":"2013","journal-title":"Breast Care (Basel)"},{"key":"10.1016\/j.jss.2025.01.010_bib34","doi-asserted-by":"crossref","first-page":"297","DOI":"10.4048\/jbc.2017.20.3.297","article-title":"Comparison of core needle biopsy and surgical specimens in determining intrinsic biological subtypes of breast cancer with immunohistochemistry","volume":"20","author":"You","year":"2017","journal-title":"J Breast Cancer"},{"key":"10.1016\/j.jss.2025.01.010_bib35","doi-asserted-by":"crossref","first-page":"145","DOI":"10.11622\/smedj.2016062","article-title":"Concordance between core needle biopsy and surgical specimen for oestrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 status in breast cancer","volume":"58","author":"Asogan","year":"2017","journal-title":"Singapore Med J"},{"key":"10.1016\/j.jss.2025.01.010_bib36","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s10549-015-3444-x","article-title":"Quality assessment of estrogen receptor and progesterone receptor testing in breast cancer using a tissue microarray-based approach","volume":"152","author":"Dekker","year":"2015","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.jss.2025.01.010_bib37","author":"Zhimin"},{"key":"10.1016\/j.jss.2025.01.010_bib38","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jamcollsurg.2012.09.007","article-title":"Does breast tumor heterogeneity necessitate further immunohistochemical staining on surgical specimens?","volume":"216","author":"Greer","year":"2013","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.jss.2025.01.010_bib39","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1097\/PAS.0000000000000424","article-title":"Reflex estrogen receptor\/progesterone receptor\/human epidermal growth factor receptor 2 (ER\/PR\/Her2) analysis of breast cancers in needle core biopsy specimens dramatically increases health care costs","volume":"39","author":"VandenBussche","year":"2015","journal-title":"Am J Surg Pathol"}],"container-title":["Journal of Surgical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022480425000289?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022480425000289?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T04:21:39Z","timestamp":1777350099000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022480425000289"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":38,"alternative-id":["S0022480425000289"],"URL":"https:\/\/doi.org\/10.1016\/j.jss.2025.01.010","relation":{},"ISSN":["0022-4804"],"issn-type":[{"value":"0022-4804","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expression and Subtype Discordance Between Core Needle Biopsy and Surgical Specimen in Breast Cancer","name":"articletitle","label":"Article Title"},{"value":"Journal of Surgical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jss.2025.01.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}